What is Nykode Therapeutics AS (NYKD.OL)?

Nykode Therapeutics AS (NYKD.OL) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

Nykode Therapeutics AS (NYKD.OL)

Stock analysis · OSL · Healthcare · Biotechnology

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.86

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Nykode Therapeutics AS (NYKD.OL) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Feb 25, 2026

EPS $-0.25 vs est. $-0.20

Missed by $0.05

Proprietary Signals

Signal snapshot temporarily unavailable.

About Nykode Therapeutics AS

Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases. The company develops vaccines for the treatment cancer, autoimmune, and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of locally advanced and metastatic tumors; and VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer. Nykode Therapeutics AS was founded in 2006 and is headquartered in Oslo, Norway.